Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 20, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000068.pdf 0001968202-24-000068.xls
Feb 16, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000066.pdf 0001968202-24-000066.xls
Feb 14, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-24-000537.pdf 0001958244-24-000537.xls
Feb 13, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000064.pdf 0001968202-24-000064.xls
Feb 13, 2024	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001104659-24-021814.pdf
Feb 12, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000062.pdf 0001968202-24-000062.xls
Feb 12, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000061.pdf 0001968202-24-000061.xls
Feb 09, 2024	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-24-001496.pdf
Feb 09, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-24-000075.pdf 0001969223-24-000075.xls
Feb 09, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-000780.pdf

Data provided by Kaleidoscope.

Investors & Media